Laurent Levy

Laurent Levy, listed as chief executive, has filed trades across 2 companies (mainly through AMF), most often in Nanobiotix and Valbiotis. We count 4 filings; the first trade dates from 11 May 2022 and the latest from 26 November 2025.

On the market, this insider has only sold: 1 sale, €5.1M in total. Outside the open market, there are 1 share grant. 2025 to date brings no purchases and 1 sale.

Most recently, on 3 December 2025, the filings show an open-market sale worth €5.1M in Nanobiotix. Between a trade and the moment it shows up on AMF, the median delay is 28 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.